World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01414751
Date of registration: 05/08/2011
Prospective Registration: No
Primary sponsor: University of Southern Denmark
Public title: Influence of Intervention Methodologies on Patient Choice of Therapy IMPACT
Scientific title: Interventions for Chronic Diseases: Effect of Patient Values and Effectiveness Information on Patients' Choice of Therapy, Adherence to Therapy and Satisfaction With Therapy
Date of first enrolment: November 2009
Target sample size: 248
Recruitment status: Active, not recruiting
URL:  http://clinicaltrials.gov/show/NCT01414751
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)  
Phase:  N/A
Countries of recruitment
Contacts
Name:     Dorte E Jarbol, MD PhD
Address: 
Telephone:
Email:
Affiliation:  Research Unit of General Practice, Institute of Public Health, University of Southern Denmark
Key inclusion & exclusion criteria

Inclusion Criteria:

- 40-69 year-olds

- Patients with a measured total-cholesterol of > 4 MMol/Litre

Exclusion Criteria:

- Patients with diabetes

- Patients with known chronic cardiovascular diseases

- Patients who are already being treated with cholesterol lowering therapy

- Patients who are not familiar with the danish language



Age minimum: 40 Years
Age maximum: 69 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Hypercholesterolemia
Communication
Intervention(s)
Behavioral: Prolongation of life
Behavioral: Absolute risk reduction
Primary Outcome(s)
Patient's satisfaction and confidence with the information given. [Time Frame: Within two weeks after receiving the information and after 3 months.]
Secondary Outcome(s)
Influence of effectiveness format on patients' consent or refusal to a therapy offer [Time Frame: Within the first week after receiving the information and during the following year.]
Secondary ID(s)
CGH001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Danish Heart Foundation
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history